These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3629187)

  • 1. Urinary excretion of aluminium after ingestion of sucralfate and an aluminium-containing antacid in man.
    Haram EM; Weberg R; Berstad A
    Scand J Gastroenterol; 1987 Jun; 22(5):615-8. PubMed ID: 3629187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of aluminium-containing antacid absorption in man.
    Nagy E; Jobst K
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):119-21. PubMed ID: 8031961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal absorption of aluminium from single doses of aluminium containing antacids in man.
    Weberg R; Berstad A
    Eur J Clin Invest; 1986 Oct; 16(5):428-32. PubMed ID: 3100311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir.
    Krishna R; East L; Larson P; Valiathan C; Butterfield K; Teng Y; Hernandez-Illas M
    J Pharm Pharmacol; 2016 Nov; 68(11):1359-1365. PubMed ID: 27671833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of concomitant drugs on the blood concentration of a histamine H2 antagonist (1st report). Oral administration of ranitidine together with high doses of neutralizing antacid and sucralfate].
    Kimura K; Sakai H; Yoshida Y; Kasano T; Hirose M
    Nihon Shokakibyo Gakkai Zasshi; 1986 Feb; 83(2):161-4. PubMed ID: 3754594
    [No Abstract]   [Full Text] [Related]  

  • 6. Orange juice enhances aluminium absorption from antacid preparation.
    Fairweather-Tait S; Hickson K; McGaw B; Reid M
    Eur J Clin Nutr; 1994 Jan; 48(1):71-3. PubMed ID: 8200332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kinetics of aluminum absorption and serum concentration in chronic renal insufficiency].
    Sárszegi Z; Jobst K; Nagy J
    Orv Hetil; 2000 Aug; 141(35):1915-7. PubMed ID: 11019592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and In vivo evaluations of a tableted antacid and sucralfate, a new antiulcer agent.
    McGraw BF; Hesterlee EJ; Lanza FL; Tesler MA
    Am J Gastroenterol; 1981 Nov; 76(5):412-5. PubMed ID: 6895973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antacid action of the aluminum cation: comparison of the in vitro effect of hydroxide and phosphate in open and closed systems].
    Vatier J; Lionnet F; Vitre MT
    Gastroenterol Clin Biol; 1987 Nov; 11(11):758-63. PubMed ID: 3428519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short report: plasma aluminium concentration and 24-hour urinary aluminium excretion before, during and after treatment with sucralfate.
    Mistry P; Varghese Z; Pounder RE
    Aliment Pharmacol Ther; 1991 Oct; 5(5):549-53. PubMed ID: 1793786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric prostaglandin E2 release induced by aluminium hydroxide and aluminium hydroxide-containing antacids in rats. Effect of low doses and citric acid.
    Berstad K; Vergin H; Postius S; Weberg R; Szelenyi I; Berstad A
    Scand J Gastroenterol; 1987 Sep; 22(7):884-8. PubMed ID: 3478796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids.
    Snell P; Oo C; Dorr A; Barrett J
    Br J Clin Pharmacol; 2002 Oct; 54(4):372-7. PubMed ID: 12392584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antacid interaction with new quinolones: dose regimen recommendations based on pharmacokinetic modeling of clinical data for ciprofloxacin, gatifloxacin and norfloxacin and metal cations.
    Miyata K; Ohtani H; Tsujimoto M; Sawada Y
    Int J Clin Pharmacol Ther; 2007 Jan; 45(1):63-70. PubMed ID: 17256452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers.
    Krishna G; Kisicki JC; Olsen S; Grasela DM; Wang Z
    Pharmacotherapy; 2007 Jul; 27(7):963-9. PubMed ID: 17594201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sucralfate and alginate/antacid in reflux esophagitis.
    Laitinen S; Ståhlberg M; Kairaluoma MI; Kiviniemi H; Pääkkönen M; Lahtinen J; Poikolainen E; Aukee S
    Scand J Gastroenterol; 1985 Mar; 20(2):229-32. PubMed ID: 2986275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of routine doses of antacid on renal acidification.
    Stemmer CL; Oster JR; Vaamonde CA; Perez GO; Rogers AI
    Lancet; 1986 Jul; 2(8497):3-6. PubMed ID: 2873325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma and urine aluminium concentrations in healthy subjects after administration of sucralfate.
    Allain P; Mauras Y; Krari N; Duchier J; Cournot A; Larcheveque J
    Br J Clin Pharmacol; 1990 Apr; 29(4):391-5. PubMed ID: 2328192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of the ciprofloxacin-antacid interaction.
    Roush MK; Dupuis RE
    DICP; 1991 May; 25(5):473-5. PubMed ID: 2068831
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in the transmural electric potential difference in the region of stomach ulcer. Local effect of sucralfate, aluminum hydroxide and magnesium trisilicate].
    Möckel W; Hausding P
    Fortschr Med; 1984 Jul; 102(25-26):709-12. PubMed ID: 6547921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of omeprazole or of an aluminium hydroxide/magnesium hydroxide antacid on the pharmacokinetics of lumiracoxib.
    Scott G; Vinluan Reynolds C; Milosavljev S; Langholff W; Shenouda M; Rordorf C
    Clin Pharmacokinet; 2004; 43(5):341-8. PubMed ID: 15080766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.